One plan - full access

No subscription, no auto-renewal, no hidden terms.
Pay once and use it for 30 days.

PRO plan No auto-renewal
$18

30 days of full access
One-time payment

🌐 US & Global Companies
Get access for 30 days →
♧ Secure payment · Instant access

What is included

  • ✓Full access to detailed company analysis
  • ✓Fundamental screener
  • ✓Advanced stock screener filters
  • ✓5 ratings. Separate lists for US & Global Companies and MOEX
  • ✓Company data export in XLSX and CSV
  • ✓MarketCap’s overall ranking of top companies
  • ✓Analytics updates after each new financial report
⚠ The service is not an investment advisor. Financial statement data from public companies is available to everyone - MarketCap structures and analyzes it.
Quotient Limited logo
Quotient Limited QTNT
report update icon

Quarterly report 2023-Q3
added 05-23-2026

Quotient Limited Balance Sheet 2022-2011 | QTNT

Brief overview of Quotient Limited's balance sheet structure

The comparison uses five available annual reports from the 2018–2022 interval.

Assets reached $194 million, compared with $123.8 million at the beginning. Growth of +56.6% and CAGR near 11.9% show active expansion.

Liabilities expanded faster than the asset base, +144.2% versus +56.6%. Debt-service capacity deserves attention.

Shareholders' capital is negative, making the balance sheet dependent on consistent debt servicing capacity.

Cash equals 33.5% of the balance sheet, compared with 16.3% five periods ago. This is the readily available cushion.

Retained earnings are negative at -$725 million. This reduces the formal capital cushion, although large shareholder returns may have contributed.

What the balance sheet shows

Quotient Limited's financial structure calls for caution. Stronger equity, lower debt or restored liquidity would be needed to improve it.

Annual Balance Sheet Quotient Limited

2022 2021 2020 2019 2018 2017 2016 2015 2014 2013 2012 2011

Net Debt

172 M 78.6 M 145 M 116 M 63.8 M 79.2 M -14.1 M -22.5 M 7.91 M -1.22 M -1.26 M -

Long Term Debt

233 M 121 M 145 M 120 M 84 M 84 M 29 M 10.5 M 15.1 M 3 M 3 M -

Long Term Debt Current

3.54 M 3.45 M 3.31 M - - - 1 M 4.5 M - - - -

Total Non Current Liabilities

- - 201 M 151 M 111 M 104 M 51.7 M 28 M 48.4 M 31.3 M 26.8 M -

Total Current Liabilities

32.8 M 59.5 M 50.4 M 25.4 M 27.1 M 29.7 M 21.4 M 54.8 M 12.9 M - - -

Total Liabilities

338 M 255 M 244 M 176 M 138 M 134 M 73 M 81.8 M 30.6 M 36 M 31 M -

Retained Earnings

-725 M -600 M -561 M -381 M -276 M -193 M -108 M -74.4 M -15.3 M -5.13 M -416 K -

Total Assets

194 M 220 M 247 M 178 M 124 M 110 M 120 M 80.2 M 29.8 M 12.9 M 12.4 M -

Cash and Cash Equivalents

65.1 M 45.7 M 3.4 M 4.1 M 20.2 M 4.75 M 44.1 M 37.5 M 7.19 M 4.22 M - -

Book Value

-144 M -35.6 M 2.24 M 1.71 M -14.6 M -24.1 M 46.7 M -1.62 M -773 K -23.1 M -18.7 M -

Total Shareholders Equity

-144 M -35.6 M -8.49 M 709 K -15.2 M -24.1 M 46.7 M -1.62 M -31.5 M -23.1 M - -

All numbers in USD currency

Quarterly Balance Sheet Quotient Limited

2023-Q3 2023-Q2 2023-Q1 2022-Q4 2022-Q3 2022-Q2 2022-Q1 2021-Q4 2021-Q3 2021-Q2 2021-Q1 2020-Q4 2020-Q3 2020-Q2 2020-Q1 2019-Q4 2019-Q3 2019-Q2 2019-Q1 2018-Q4 2018-Q3 2018-Q2 2018-Q1 2017-Q4 2017-Q3 2017-Q2 2017-Q1 2016-Q4 2016-Q3 2016-Q2 2016-Q1 2015-Q4 2015-Q3 2015-Q2 2015-Q1 2014-Q4 2014-Q3 2014-Q2 2014-Q1 2013-Q4 2013-Q3 2013-Q2 2013-Q1 2012-Q4 2012-Q3 2012-Q2 2012-Q1 2011-Q4 2011-Q3 2011-Q2 2011-Q1

Long Term Debt

240 M 221 M 236 M 240 M 229 M 232 M 103 M 229 M 121 M 133 M 145 M 121 M 145 M 145 M 145 M 145 M 120 M 110 M 110 M 120 M 110 M 110 M 84 M 84 M 84 M 84 M 84 M 84 M 30 M 30 M 9 M 30 M 12.2 M 13.7 M 15.2 M 12.2 M 13.7 M 15.2 M 15.1 M - - - - - - - - - - - -

Total Liabilities

328 M 310 M 326 M 328 M 334 M 335 M 338 M 334 M 238 M 238 M 231 M 244 M 230 M 224 M 215 M 230 M 166 M 169 M 167 M 166 M 169 M 167 M 138 M 134 M 134 M 139 M 134 M 129 M 63.4 M 74.8 M 81.9 M 63.4 M 74.5 M 38.5 M 35.1 M 74.5 M 38.5 M 35.1 M 30.6 M - - - - - - - - - - - -

Retained Earnings

-823 M -810 M -764 M -823 M -699 M -654 M -627 M -699 M -554 M -524 M -509 M -561 M -459 M -431 M -404 M -459 M -354 M -328 M -301 M -354 M -328 M -301 M -276 M -256 M -256 M -235 M -214 M -173 M -98.7 M -88.9 M -84.5 M -98.7 M -71.9 M -29.6 M -17.9 M -71.9 M -29.6 M -17.9 M -15.3 M - - - - - - - - - - - -

Total Assets

119 M 128 M 175 M 119 M 209 M 250 M 277 M 209 M 246 M 272 M 201 M 247 M 248 M 177 M 193 M 248 M 191 M 155 M 131 M 191 M 155 M 131 M 124 M 138 M 138 M 122 M 139 M 124 M 89.6 M 84.4 M 73.6 M 89.6 M 66.6 M 48.5 M 58.5 M 66.6 M 48.5 M 58.5 M 29.8 M - - - - - - - - - - - -

Cash and Cash Equivalents

11.9 M 24.5 M 46.2 M 11.9 M 85.1 M 121 M 115 M 85.1 M 3.4 M 18.1 M 7.32 M 3.4 M 4.66 M 5.82 M 6.53 M 4.66 M 4.47 M 3.56 M 35.6 M 4.47 M 4.47 M 3.56 M 20.2 M 6.15 M 6.15 M 9.13 M 13 M 14.3 M 24.1 M 25.7 M 21.3 M 24.1 M 33 M 17.1 M 32 M 33 M 17.1 M 32 M 7.19 M 13.8 M 1.54 M 1.74 M 4.22 M - - - 4.35 M - - - -

Book Value

-209 M -182 M -151 M -209 M -126 M -85.3 M -61.2 M -126 M 7.67 M 33.7 M -30.2 M 2.24 M 18.1 M -46.9 M -21.2 M 18.1 M 24.7 M -14.7 M -36.2 M 24.7 M -14.7 M -36.2 M -14.6 M 3.82 M 3.82 M -16.4 M 4.47 M -5.08 M 26.1 M 9.66 M -8.36 M 26.1 M -7.94 M 9.9 M 23.4 M -7.94 M 9.9 M 23.4 M -773 K - - - - - - - - - - - -

Total Shareholders Equity

-209 M -182 M -151 M -209 M -126 M -85.3 M -61.2 M -126 M 7.67 M 33.7 M -30.2 M 2.24 M 18.1 M -46.9 M -21.2 M 18.1 M 24.7 M -14.7 M -36.2 M 24.7 M 24.7 M -14.7 M -15.2 M 3.82 M 3.82 M -16.4 M 4.47 M -5.08 M 26.1 M 9.66 M -8.36 M 26.1 M -7.94 M 9.9 M 23.4 M -7.94 M 9.9 M 23.4 M -31.5 M - - - -23.1 M - - - -18.7 M - - - -

All numbers in USD currency

Balance Sheet is a fundamental financial report of Quotient Limited, providing a complete picture of the company’s financial position at a specific point in time. Unlike the income statement, which records the results of operations over a certain period, the balance sheet shows what assets the company owns, what liabilities it has to creditors, and what equity is available to the owners.

For an investor, the balance sheet is important because it allows assessing the company’s financial stability, understanding how much debt it carries, and how dependent it is on borrowed financing. It helps calculate key liquidity and leverage ratios. When analyzing, attention should be paid to the debt-to-equity ratio (Debt/Equity), the amount of cash on the balance sheet, and the ratio of current liabilities to liquid assets.

Features of balance sheet analysis
  • Vertical and horizontal analysis
    Vertical analysis shows the structure of the balance sheet as a percentage of total assets or liabilities, while horizontal analysis shows the dynamics of changes over multiple periods.
  • Asset quality
    It is important to evaluate not only the amount of assets but also their liquidity and realizability.
  • Accounting for off-balance sheet liabilities
    Some liabilities may not be directly reflected in the balance sheet, which requires additional attention.

Balance sheet of other industry stocks – Diagnostics research

Issuer Price % 24h Market Cap Country
Enzo Biochem Enzo Biochem
ENZ
- -8.98 % $ 14.8 K usaUSA
Chembio Diagnostics Chembio Diagnostics
CEMI
- 0.22 % $ 16.8 M usaUSA
Renalytix AI plc Renalytix AI plc
RNLX
- 5.66 % $ 22.7 M britainBritain
Meridian Bioscience Meridian Bioscience
VIVO
- - $ 1.49 B usaUSA
Heska Corporation Heska Corporation
HSKA
- - $ 1.31 B usaUSA
Accelerate Diagnostics Accelerate Diagnostics
AXDX
- -61.36 % $ 2.46 M usaUSA
T2 Biosystems T2 Biosystems
TTOO
- -39.35 % $ 313 K usaUSA
Syneos Health Syneos Health
SYNH
- - $ 4.46 B usaUSA
Biocept Biocept
BIOC
- -13.05 % $ 7.29 M usaUSA
Invitae Corporation Invitae Corporation
NVTA
- - $ 21.2 M usaUSA
Brainsway Ltd. Brainsway Ltd.
BWAY
$ 8.53 -2.29 % $ 290 M israelIsrael
Burning Rock Biotech Limited Burning Rock Biotech Limited
BNR
$ 13.46 1.05 % $ 142 M chinaChina
Medpace Holdings Medpace Holdings
MEDP
$ 609.81 -3.81 % $ 17.6 B usaUSA
DermTech DermTech
DMTK
- -11.32 % $ 2.94 M usaUSA
Surmodics Surmodics
SRDX
- - $ 608 M usaUSA
RadNet RadNet
RDNT
$ 69.77 0.37 % $ 5.25 B usaUSA
Akumin Akumin
AKU
- -17.87 % $ 25.9 M canadaCanada
Psychemedics Corporation Psychemedics Corporation
PMD
- -1.84 % $ 15.3 M usaUSA
IDEXX Laboratories IDEXX Laboratories
IDXX
$ 675.24 -2.09 % $ 54.3 B usaUSA
Motus GI Holdings Motus GI Holdings
MOTS
- -34.28 % $ 263 K israelIsrael
Biodesix Biodesix
BDSX
$ 7.55 -9.1 % $ 57 M usaUSA
HTG Molecular Diagnostics HTG Molecular Diagnostics
HTGM
- -20.0 % $ 1.06 M usaUSA
Agilent Technologies Agilent Technologies
A
$ 169.82 -3.21 % $ 48.2 B usaUSA
Charles River Laboratories International Charles River Laboratories International
CRL
$ 314.38 -4.13 % $ 15.6 B usaUSA
Quest Diagnostics Incorporated Quest Diagnostics Incorporated
DGX
$ 257.78 -0.4 % $ 28.6 B usaUSA
Danaher Corporation Danaher Corporation
DHR
$ 220.3 -3.19 % $ 157 B usaUSA
DexCom DexCom
DXCM
$ 79.02 -1.46 % $ 30.8 B usaUSA
Anixa Biosciences Anixa Biosciences
ANIX
$ 2.44 -6.15 % $ 79.2 K usaUSA
Celcuity Celcuity
CELC
$ 53.32 -5.31 % $ 2.49 B usaUSA
Guardant Health Guardant Health
GH
$ 145.9 0.21 % $ 18.3 B usaUSA
BioNano Genomics BioNano Genomics
BNGO
$ 0.82 -7.56 % $ 4.46 M usaUSA
Bioventus Bioventus
BVS
$ 9.89 -0.65 % $ 659 M usaUSA
IQVIA Holdings IQVIA Holdings
IQV
$ 245.67 -1.92 % $ 42.2 B usaUSA
Laboratory Corporation of America Holdings Laboratory Corporation of America Holdings
LH
$ 367.68 -0.44 % $ 30.6 B usaUSA
Castle Biosciences Castle Biosciences
CSTL
$ 32.69 -2.14 % $ 948 M usaUSA
Mettler-Toledo International Mettler-Toledo International
MTD
$ 1 667.59 -2.3 % $ 34.4 B schweizSchweiz
Illumina Illumina
ILMN
$ 192.79 -3.92 % $ 29.9 B usaUSA
Natera Natera
NTRA
$ 273.11 -5.8 % $ 37.3 B usaUSA
Koninklijke Philips N.V. Koninklijke Philips N.V.
PHG
$ 28.63 -2.22 % $ 27.1 B niderlandNiderland
Fulgent Genetics Fulgent Genetics
FLGT
$ 24.03 -3.03 % $ 740 M usaUSA
CareDx, Inc CareDx, Inc
CDNA
$ 69.9 -2.81 % $ 3.72 B usaUSA
Oxford Immunotec Global PLC Oxford Immunotec Global PLC
OXFD
- - $ 562 M britainBritain
Biomerica Biomerica
BMRA
$ 1.09 -0.46 % $ 3.18 M usaUSA
Interpace Biosciences Interpace Biosciences
IDXG
$ 4.4 -4.35 % $ 19.5 M usaUSA
Lantheus Holdings Lantheus Holdings
LNTH
$ 102.12 0.01 % $ 6.89 B usaUSA
Senseonics Holdings Senseonics Holdings
SENS
$ 8.03 -9.88 % $ 335 M usaUSA
Sotera Health Company Sotera Health Company
SHC
$ 15.92 -1.82 % $ 4.52 B usaUSA
Fluidigm Corporation Fluidigm Corporation
FLDM
- 1.08 % $ 308 M usaUSA
ICON Public Limited Company ICON Public Limited Company
ICLR
$ 186.79 -1.88 % $ 14.6 B irlandaIrlanda